Latest filing published 05 Jun 2023 for ImmunityBio, Inc., €19k.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Wesley Clark span 7 companies, the busiest being root9B Technologies, Inc., Rentech, Inc. and Argyle Security Acquisition Corp. Over a trading history stretching from 1 February 2006 to 1 June 2023, the count stands at 46 filings.
On the open market, the record shows 10 purchases worth €84k and 10 sales worth €123k. On balance, insiders were net sellers of €38k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 13 share grants and 12 option exercises. In 2023 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €3,909 and half below. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 75% of cases, with a median move of +1.6%. These figures describe past trades and do not predict future prices.
Most recently, on 5 June 2023, the filings show an open-market purchase worth €19k in ImmunityBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 46 declarations